Source: BECKER'S SPINE REVIEW

Spinal Modulation: Spinal Modulation completes enrollment for pivotal neurostimulator system trial: 3 things to know

Spinal Modulation completed enrollment of a clinical trial designed to evaluate the safety and efficacy of its Axium Neurostimulator System.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
David Wood's photo - President & CEO of Spinal Modulation

President & CEO

David Wood

CEO Approval Rating

68/100

Read more